Featured
Merck KGaA Acquires Bio-Techne in Massive $11.3 Billion Cash Deal
In a landmark $11.3 billion all-cash deal, Merck KGaA has agreed to acquire Bio-Techne Corporation. This strategic move significantly expands Merck's ...
Read Full Story →Recent Articles
CybersecurityGeneEdit Achieves Breakthrough with In-Vivo CRISPR Cure for Inherited Blindness in Clinical Trials
Biotech startup GeneEdit has achieved a historic medical breakthrough, using in-vivo CRISPR gene edi...
StartupsGeneEdit Achieves Breakthrough with In-Vivo CRISPR Cure for Inherited Blindness in Clinical Trials
Biotech startup GeneEdit has achieved a historic medical breakthrough, using in-vivo CRISPR gene edi...
Nutrition & FitnessPrecision Fermentation: The Bioavailable Heme Iron Revolution for Vegan Athletes
A 2026 breakthrough in precision fermentation has created bio-identical vegan heme iron, solving the...
HealthPartial Epigenetic Reprogramming Using Transient Yamanaka Factors Reverses Biological Age in Human Clinical Trial
Altos Labs reports the first human clinical data showing that transient, partial epigenetic reprogra...
HealthVertex Pharmaceuticals Reports Long-Term Durability of CRISPR Base Editing for Sickle Cell Disease and Beta-Thalassemia
Vertex Pharmaceuticals releases five-year follow-up data for exa-cel, the CRISPR-based gene-editing ...
EntertainmentRihanna’s Fenty Beauty Launches Biotech Skincare Line via Synthetic Biology Partnership
Rihanna's Fenty Beauty has launched 'Fenty Bio-Active', a skincare line developed via synthetic biol...